Ascentage Pharma Group International - Unsponsored ADR (AAPG)
(Delayed Data from NSDQ)
$42.00 USD
+4.40 (11.70%)
Updated Aug 5, 2025 03:43 PM ET
After-Market: $41.80 -0.20 (-0.48%) 5:24 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AAPG 42.00 +4.40(11.70%)
Will AAPG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AAPG based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AAPG
Ascentage Pharma to Participate in Evercore China Biotech Summit | AAPG Stock News
Ascentage Pharma Group International to Participate in BTIG Virtual Biotechnology Conference | ...
Ascentage Pharma Group International Announces Successful Offshore Placement | AAPG stock news
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement | AAPG Stock News
Ascentage Pharma Announces Pricing of Top-Up Placement | AAPG Stock News